BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 580391)

  • 1. [Amikacin and kanamycin. Comparative experimental studies on nephrotoxicity].
    Züllich B; Sack K
    Arzneimittelforschung; 1978; 28(2):271-8. PubMed ID: 580391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study on renal tolerability of aminoglycosides butirosin and bekanamycin (author's transl)].
    Beck H; Eikenberg P; Sack K
    Arzneimittelforschung; 1980; 30(2):288-94. PubMed ID: 6155127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental studies in animals on the nephrotoxicity of some new cephalosporin antibiotics: cefamandole, EMD 29 645, and 29 946 (author's transl)].
    Beck H; Nierhoff N; Sack K
    Arzneimittelforschung; 1980; 30(4):660-6. PubMed ID: 7190410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies on the problem of nephrotoxicity of the aminoglycosides: kanamycin, amikacin, butirosin and kanendomycin].
    Sack K; Züllich B; Eikenberg P
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1538-40. PubMed ID: 70900
    [No Abstract]   [Full Text] [Related]  

  • 5. [The differentiation of potential nephrotoxicity of various aminoglycosides in animal experiments].
    Sack K; Freiesleben H; Züllich B; Beck H; Schulz E
    Adv Clin Pharmacol; 1978; 15():69-90. PubMed ID: 676878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amikacin nephrotoxicity in the rat.
    Houghton DC; Plamp CE; Gilbert DN; Kohlhepp SJ; Bennett WM; Porter GA; DeFehr J; Webb M
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):277-91. PubMed ID: 7217852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals.
    Inouye S; Niizato T; Shomura T; Kitasato I
    Drugs Exp Clin Res; 1989; 15(5):189-209. PubMed ID: 2791871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative nephrotoxicity of SCH 21420 and amikacin in rats.
    Rankin LI; Luft FC; Yum MN; Sloan RS; Dinwiddie CB; Isaacs LL
    Antimicrob Agents Chemother; 1979 Oct; 16(4):491-4. PubMed ID: 518078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
    Goren MP; Baker DK; Shenep JL
    Pediatr Infect Dis J; 1989 May; 8(5):278-82. PubMed ID: 2657616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Animal studies on nephrotoxicity of seven aminoglycoside antibiotics during long-term treatment (author's transl)].
    Beck H; Züllich B; Marre R; Sack K
    Arzneimittelforschung; 1979; 29(6):935-9. PubMed ID: 582787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fosfomycin: animal experiments on nephrotoxicity, pharmacokinetics and therapeutic efficacy (author's transl)].
    Lepère A; Marre R; Sack K
    Immun Infekt; 1980; 8(3):101-7. PubMed ID: 7461697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity induced by gentamicin and amikacin.
    Smith CR; Maxwell RR; Edwards CQ; Rogers JF; Lietman PS
    Johns Hopkins Med J; 1978 Mar; 142(3):85-90. PubMed ID: 342789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the renal and auditory function of neonates treated with amikacin.
    Parini R; Rusconi F; Cavanna G; Vigliani E; Cornacchia L; Assael BM
    Dev Pharmacol Ther; 1982; 5(1-2):33-46. PubMed ID: 7151635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
    de Jager P; van Altena R
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymuria in aminoglycoside-induced kidney damage. Comparative study of gentamicin, amikacin, sisomicin and netilmicin.
    Palla R; Marchitiello M; Tuoni M; Cirami C; Giovannini L; Bertelli AA; Bertelli A
    Int J Clin Pharmacol Res; 1985; 5(5):351-5. PubMed ID: 2866167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial spectrum, pharmacology, adverse effects, and therapeutic use of amikacin sulfate.
    Pien FD; Ho PW
    Am J Hosp Pharm; 1981 Jul; 38(7):981-9. PubMed ID: 7020413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
    Liu J; Habeebu SS; Liu Y; Klaassen CD
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Netilmicin and tobramycin: comparative evaluation of pharmacokinetics, nephrotoxicity, and therapeutic efficacy in animal studies (author's transl)].
    Marre R; Abraham M; Freiesleben H; Sack K
    Arzneimittelforschung; 1979; 29(6):940-5. PubMed ID: 582788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin].
    Bopp S; Marre R; Schulz E; Sack K
    Arzneimittelforschung; 1981; 31(3):473-7. PubMed ID: 7194672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of amikacin (BB-K8), an aminoglycoside antibiotic.
    Hirth RS
    Vet Pathol; 1975; 12(1):68-9. PubMed ID: 1166584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.